key: cord-0024780-rmnrozyd authors: Ghanemi, Abdelaziz; Yoshioka, Mayumi; St-Amand, Jonny title: Ageing and Obesity Shared Patterns: From Molecular Pathogenesis to Epigenetics date: 2021-11-29 journal: Diseases DOI: 10.3390/diseases9040087 sha: 92ba9a20dc4925fb1c4323787f305f3788c064a1 doc_id: 24780 cord_uid: rmnrozyd In modern societies, ageing and obesity represent medical challenges for healthcare professionals and caregivers. Obesity and ageing share common features including the related cellular and molecular pathways as well as the impacts they have as risk factors for a variety of diseases and health problems. Both of these health problems also share exercise and a healthy lifestyle as the best therapeutic options. Importantly, ageing and obesity also have common epigenetic changes (histone modification, DNA methylation, noncoding RNAs, and chromatin remodeling) that are also impacted by exercise. This suggests that epigenetic pathways are among the mechanisms via which exercise induces its benefits, including ageing and obesity improvements. Exploring these interrelations and based on the fact that both ageing and obesity represent risk factors for each other, would lead to optimizing the available therapeutic approaches towards improved obesity management and healthy ageing. Ageing and obesity are major topics in biomedical studies, mainly because both represent risk factors for numerous diseases and health conditions [1] . The modern lifestyle and industrial development have increased obesity rates as well as the aged population percentage worldwide. Obesity is specifically increasing among the elderly [2, 3] , which contributes to sarcopenic obesity, a chronic, age-related class of obesity [4, 5] . These interactions between two important risk factors strengthen the need to further deepen our biological and clinical understanding of the interrelation and correlations between ageing and obesity. Such mechanistic elucidation would allow to develop the medical care including geriatrics and obesity management, among other chronic diseases. Within this piece of writing, we aim to elucidate selected links between ageing and obesity through different illustrations starting from pathogenesis and molecular pathways towards epigenetics, supported by evidences from exercise being a therapeutic tool for both. Obesity is defined as an abnormal accumulation of adiposity resulting from a disturbed energy balance in which energy intake is higher than energy expenditure [6] with a modified metabolic phenotype [7] , complex neuroendocrine changes [8] , and pathogenic implications [9] . Obesity has even been classified as a disease [10] and associated with health problems including impaired fertility [11, 12] , neurodegenerative disease [13] , cognitive decline (in mid-life) [14] , coronavirus disease 2019 (COVID-19) severity and resulting health problems [15] [16] [17] [18] Although the risks related to obesity are independent from ageing and those related to ageing are independent from obesity, such similarities between ageing and obesity as risk factors suggest common patterns and share underlying mechanisms of both ageing and obesity. Early epidemiologic data approved the prevalence of obesity increases by ageing, especially in women. Therefore, the ongoing step is to know more about how ageing and obesity could be related at the molecular level. Within this context, obesity and ageing have been described as sharing common pathways at the molecular and cellular levels. For instance, in both, we have increased inflammation [49, 50] , free radicals, and oxidative stress [51, 52] as well as microbiota changes [53, 54] . In addition, healthy diet and physical activity are prescribed to manage obesity [55, 56] and also optimize healthy ageing [57, 58] . While the main goal of prescribing the physical activity in obesity is to increase the energy expenditure and, thus, reduce the adiposity and lose weight [59, 60] , in ageing, the physical activity aims mostly to improve muscular and metabolic performance [57, 61, 62] . Importantly, physical activity as a common therapy for both ageing and obesity has significant impacts on reducing the risk factors mediated by ageing and obesity and also improves numerous biomolecular markers and pathological profiles. As illustrations, physical activity improves and optimizes treatment/prevention or reduces the risk of metabolic disorders [63] , cancer [64] , cardiovascular disease [65] [66] [67] , immune functions [68] , insulin resistance [69] , oxidative stress [70] , liver disease [71] , regeneration [72, 73] , pulmonary disease [74, 75] , atherosclerosis [76] , and mitochondrial remodeling [77] . These evidences add up on those of functional genomics [78] [79] [80] [81] as illustrated by the secreted protein acidic and rich in cysteine (SPARC). Indeed, SPARC expression changes during obesity [82] and with ageing [83] and Sparc/SPARC represents an exercise-induced gene upon which exercise-induced muscle phenotype changes would depend [84, 85] . In addition, SPARC is involved in diverse biological activities [86] related to those described above in the context of obesity, ageing, and exercise. These include metabolic and homeostatic properties [87] , inflammation [88] , cancer [89] , regeneration [90] , and metabolism [91] . This exercise-induced key myokine with obesity and age-related expression patterns further points to molecular links between obesity and ageing. Furthermore, epigenetics studies provide additional evidences of similar patterns shared by obesity and ageing. Therefore, epigenetics represents a field worth exploring to reveal further links between obesity and ageing. This is reflected by the changes such as histone modification, DNA methylation, noncoding RNAs, and chromatin remodeling that have been associated with both ageing [31, [92] [93] [94] [95] [96] [97] and obesity [98] [99] [100] [101] [102] [103] . These changes can follow diverse patterns. For instance, region-specific DNA hypermethylation [104] and proliferation-dependent alterations of the DNA methylation [105] have been reported in ageing during which we talk about epigenetic clocks [106] . The possible use of DNAmethylation-based measures as a tool to evaluate the accelerated biological ageing [107] [108] [109] [110] represents a potential application of the DNA methylation age (DNAmAge), which would contribute to several diseases such as obesity. Similarly, obesity-related DNA methylation can be site-specific [111] and with specific methylation signatures [112] . Other related features such as telomere attrition are also shared between ageing [31] and obesity [113, 114] . Importantly, exercise-prescribed for both elderly and obese patients-has impacts on the epigenetics patterns related to both ageing and obesity including DNA methylation [115] , histone modification [116] , chromatin modifications [117] , and noncoding RNAs [118] . These exercise-related properties suggest that epigenetics pathways are among the mechanisms via which exercise induces its benefits-as it has been shown, for instance, for exercise-mediated heart protection [119] . They further support targeting epigenetic pathways as a therapy [120, 121] as well; potentially, to treat obesity and improve ageing. These observations also suggest correlations between epigenetics changes and obesity/ageing-related pathologic phenotypes. In addition, these molecular and clinical evidences, from genetics to epigenetics and pathogenesis, further present obesity as a risk factor for ageing and, at the same time, highlight ageing as a risk factor for obesity [1] . This would explain why losing weight "rejuvenates". Moreover, dietary restriction (that has both antiageing and antiobesity effects) also impacts epigenetics towards significant health benefits [122, 123] bringing an additional correlation between ageing and obesity. These introduced concepts would have important applications in the medical fields, especially that both ageing and obesity are among what medically characterize the epidemiological and pathological profiles of most modern societies. Although a healthy ageing is the optimum target of geriatrics, we have limited options to manage ageing (irreversible time effects). However, obesity, on the other hand, has realistically more management options since it remains relatively reversible. Therefore, managing obesity toward healthy ageing remains more practical than targeting healthy ageing to manage obesity. It is worth noting, however, that treating obesity would optimize ageing and healthy ageing would decrease obesity risk. Nevertheless, the key approach remains to target a healthy lifestyle including exercise, diet, sleeping, and psychological well-being to manage obesity, optimize healthy ageing, and control most diseases' risk factors. We would like to introduce a new concept via which there is a potential to combine the age-related and the obesity-related epegentics measures to obtain a full evaluation of how deep both the age and obesity worsen the other as well as the various diseases and risk factos for which either ageing or obesity represent a risk factor. The need to actualize this idea nowadays comes from the urgent epedemiological situations related to ageing and obesity in the modern societies both in developed and in developing countries. To expand this vision, the advances and added value of this work is that it puts epigenetics along with pathological phenotype, molecular patterns, and lifestyle impacts as a set that regroups the elements shared between obesity and ageing ( Figure 1 ). Such approches would allow for optimizing therapies and lifestyle management choices. Obesity and related consequences to ageing Obesity and weight management in the elderly Obesity and weight management in the elderly: A focus on men Sarcopenic obesity in older adults: Aetiology, epidemiology and treatment strategies Sarcopenic obesity Broken Energy Homeostasis and Obesity Pathogenesis: The Surrounding Concepts The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function Obesity as a Neuroendocrine Reprogramming Obese Animals as Models for Numerous Diseases: Advantages and Applications Redefining obesity toward classifying as a disease Obesity and reduced fertility of men Linking Gut Microbiota and Inflammation to Obesity and Insulin Resistance The relationship between obesity and cognitive health and decline Obesity-A risk factor for increased COVID-19 prevalence, severity and lethality (Review) Will an obesity pandemic replace the coronavirus disease-2019 (COVID-19) pandemic? Med. Hypotheses COVID-19) Crisis: Losing Our Immunity When We Need It the Most Post-Coronavirus Disease-2019 (COVID-19): Toward a Severe Multi-Level Health Crisis? Obesity and type 2 diabetes: Also linked in therapeutic options Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies The microbiota-gut-brain axis in obesity Gut instincts: Microbiota as a key regulator of brain development, ageing and neurodegeneration Diet and exercise in management of obesity and overweight The Effects of Exercise and Physical Activity on Weight Loss and Maintenance Healthy Eating Is Associated with Sarcopenia Risk in Physically Active Older Adults Exercise and Older Adults Exercise Dose and Weight Loss in Adolescents with Overweight-Obesity: A Meta-Regression The role of exercise and physical activity in weight loss and maintenance Obesity in the elderly Aerobic exercise in the elderly: A key to successful aging Interleukin-6 as a "metabolic hormone Exercise and cancer: From "healthy" to "therapeutic"? Cancer Immunol Exercise and heart failure: An update Exercise benefits in cardiovascular disease: Beyond attenuation of traditional risk factors Exercise Prescription in Patients with Different Combinations of Cardiovascular Disease Risk Factors: A Consensus Statement from the EXPERT Working Group Exercise Regulates the Immune System Exercise and Insulin Resistance The Antioxidant Effect of Exercise: A Systematic Review and Meta-Analysis The Effects of Physical Exercise on Fatty Liver Disease Exercise enhances skeletal muscle regeneration by promoting senescence in fibro-adipogenic progenitors Molecular Mechanisms of Cardiac Remodeling and Regeneration in Physical Exercise Aerobic Exercise Training in Very Severe Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis Exercise Training Modalities for People with Chronic Obstructive Pulmonary Disease Physical Exercise Is a Potential "Medicine" for Atherosclerosis Skeletal muscle mitochondrial remodeling in exercise and diseases Exercise and High-Fat Diet in Obesity: Functional Genomics Perspectives of Two Energy Homeostasis Pillars Functional genomics applications and therapeutic implications in sarcopenia Differential gene expression analysis in ageing muscle and drug discovery perspectives Identification of the principal transcriptional regulators for low-fat and high-fat meal responsive genes in small intestine SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice Exercise-Induced Myokines can Explain the Importance of Physical Activity in the Elderly: An Overview Exercise Training of Secreted Protein Acidic and Rich in Cysteine (Sparc) KO Mice Suggests That Exercise-Induced Muscle Phenotype Changes Are SPARC-Dependent Measuring Exercise-Induced Secreted Protein Acidic and Rich in Cysteine Expression as a Molecular Tool to Optimize Personalized Medicine Secreted Protein Acidic and Rich in Cysteine as a Molecular Physiological and Pathological Biomarker Secreted Protein Acidic and Rich in Cysteine: Metabolic and Homeostatic Properties beyond the Extracellular Matrix Structure Secreted protein acidic and rich in cysteine and inflammation: Another homeostatic property? Cytokine Secreted protein acidic and rich in cysteine and cancer: A homeostatic hormone? Cytokine Secreted Protein Acidic and Rich in Cysteine as a Regeneration Factor: Beyond the Tissue Repair Secreted protein acidic and rich in cysteine and bioenergetics: Extracellular matrix, adipocytes remodeling and skeletal muscle metabolism The role of DNA methylation in ageing and cancer The ageing epigenome and its rejuvenation NAD(+) metabolism and its roles in cellular processes during ageing The Aging Epigenome Non-coding RNAs in ageing Non-coding RNAs in cardiovascular ageing DNA methylation markers in obesity, metabolic syndrome, and weight loss Epigenetics in Human Obesity and Type 2 Diabetes Genome-wide associations for birth weight and correlations with adult disease Coordinated Regulation of PPARĪ³ Expression and Activity through Control of Chromatin Structure in Adipogenesis and Obesity Long Non-coding RNAs in Metabolic and Inflammatory Pathways in Obesity Epigenetic contribution to obesity Aging and DNA methylation Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging The role of DNA methylation in epigenetics of aging DNA methylation-based measures of accelerated biological ageing and the risk of dementia in the oldest-old: A study of the Lothian Birth Cohort 1921 DNAm-based signatures of accelerated aging and mortality in blood are associated with low renal function DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility Epigenetic age acceleration is associated with allergy and asthma in children in Project Viva Epigenetics and human obesity DNA methylation analysis in nonalcoholic fatty liver disease suggests distinct disease-specific and remodeling signatures after bariatric surgery FTO associations with obesity and telomere length Ethnic disparities in relationships of obesity indices with telomere length in Asians with type 2 diabetes Exercise training and DNA methylation in humans Physical exercise as an epigenetic modulator of brain plasticity and cognition Exercisedependent increases in protein synthesis are accompanied by chromatin modifications and increased MRTF-SRF signalling Long Non-coding RNAs Are Differentially Expressed after Different Exercise Training Programs Exercise Mediates Heart Protection via Non-coding RNAs Cancer epigenetics: From mechanism to therapy Epidrugs: Targeting epigenetic marks in cancer treatment Epigenetic Regulation by Dietary Restriction: Part II